BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Rentschler Biotechnologie GmbH & Co. Announces 2. Laupheimer Zelltage on Industrial Cell Culture Technology


1/30/2012 9:07:49 AM

Laupheim, Germany, January 30, 2011 / B3C newswire / - Rentschler Biotechnologie GmbH is pleased to announce the second Laupheimer Zelltage , a biennial industrial cell culture technology conference to be held on June 11-12, 2012 at Laupheim's historical castle, Schloss Großlaupheim. The aim of the Laupheimer Zelltage conferences is to provide comprehensive scientific updates on cutting-edge technologies and to discuss application-oriented topics as a means to advance protein and virus-based biologics production. The conference will bring together 200 academic and industrial experts on cell culture and process technology from all over the world. The official conference language is English.

The theme of the second Laupheimer Zelltage is “Bioprocess light”. The conference will focus on key factors that allow fast, robust, economically competitive processes. One of the sessions will be on “New Targets for Animal Cell Technology” with lectures covering increase of productivity (Dr. Martin Gawlitzek, Genentech Inc., San Francisco, USA), the prediction of productivity by gene expression analysis (Prof. Martin Clynes, Dublin City University, Ireland) and virus-based biologics as new product candidates (Dr. Markus Hörer, Rentschler Biotechnologie GmbH, Germany). The keynote lecture will be held by Prof. Manuel Carrondo (IBET, Portugal).

“Based on the success of the inaugural conference in 2010, we’ll keep the conference’s focus on the industrial aspects of cell culture technology. As one of the few conferences with this focus, the Laupheimer Zelltage is a vital opportunity to learn about trends and hear thoughtful inputs on mastering the challenges of industrial cell culture process development,” says Prof. Roland Wagner, Senior Vice President at Rentschler.

On June 11, before the first session of the conference, attendees will have the opportunity to visit Rentschler's new 1,000 L single-use facility that has recently been recognized with the 2012 Facility of the Year Award (FOYA) in the category ‘Equipment Innovation’.

About Rentschler Biotechnologie

Rentschler Biotechnologie GmbH is a global full-service contract manufacturer with more than 35 years of experience in the development, production and approval of biopharmaceuticals in compliance with international GMP standards (EMA/FDA). Rentschler Biotechnologie has nine GMP suites with volumes of 30, 50, 250, 500, 1,000 and 2,500 liters, allowing the production of material for clinical trials (phase I to III) and for market supply. Rentschler also provides regulatory advice, protein analytics, quality control, and the sterile filling of syringes and injection vials. The company is family-owned and independent and has currently about 650 employees.

Contact for more information about the conference:

Prof. Dr. Roland Wagner

Senior Vice President Development

roland.wagner@rentschler.de

Media contact:

Friederike Braun

Marketing Director

Rentschler Biotechnologie GmbH

Phone: +49 7392 701-478

friederike.braun@rentschler.de



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES